{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:20:19Z","timestamp":1790612419700,"version":"4.1.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1001\/jamacardio.2017.4228","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T12:30:54Z","timestamp":1512563454000},"page":"155","source":"Crossref","is-referenced-by-count":107,"title":["Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk"],"prefix":"10.1001","volume":"3","author":[{"given":"Benjamin M.","family":"Scirica","sequence":"first","affiliation":[{"name":"Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofri","family":"Mosenzon","sequence":"additional","affiliation":[{"name":"Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob, A.","family":"Udell","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute and Cardiovascular Division, Department of Medicine, Women\u2019s College Hospital, Toronto, Ontario, Canada"},{"name":"Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph Gabriel","family":"Steg","sequence":"additional","affiliation":[{"name":"D\u00e9partement Hospitalo-Universitaire Fibrosis, Inflammation and REmodeling, INSERM U-1148, Universit\u00e9 Paris-Diderot, H\u00f4pital Bichat, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"National Heart and Lung Institute, Imperial College, Institute of Cardiovascular Medicine and Sciences, Royal Brompton Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren K.","family":"McGuire","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KyungAh","family":"Im","sequence":"additional","affiliation":[{"name":"Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Kanevsky","sequence":"additional","affiliation":[{"name":"Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Stahre","sequence":"additional","affiliation":[{"name":"AstraZeneca R&D, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela","family":"Sj\u00f6strand","sequence":"additional","affiliation":[{"name":"AstraZeneca R&D, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itamar","family":"Raz","sequence":"additional","affiliation":[{"name":"Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Braunwald","sequence":"additional","affiliation":[{"name":"Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2017.4228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T13:20:08Z","timestamp":1519219208000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2017.4228"}},"subtitle":["Observations From the SAVOR-TIMI 53 Trial"],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2017.4228","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,1]]}}}